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Abstract
Background: Campylobacter jejuni is a significant cause of bacterial enteritis worldwide. Very little is known about
the pathogenicity mechanisms and virulence factors of this important enteropathogen. C. jejuni isolates from 166
Finnish patients, collected from July to December in 2006, were studied for the presence of putative virulence
factors and susceptibility to antimicrobials. Isolates were tested for production of g-glutamyltransferase (GGT) as
well as the presence of genes ceuE, cgtB, ciaB, cj0486, pldA, virB11, wlaN, and the gene cluster cdtABC. Bacterial
characteristics were compared to information on foreign travel history as well as information on the course and
the symptoms of disease obtained from questionnaires returned by patients.
Results: Except for one domestic isolate, antimicrobial resistance was only detected in isolates of foreign origin.
Univariate analyses showed association between bloody stools and both GGT production (p = 0.025) and the
presence of cgtB (p = 0.034). Multivariate analysis verified that GGT production was more prevalent in domestic
isolates (p < 0.0001), while the genes cj0486 (p < 0.0001) and ceuE (p < 0.0001) were associated with C. jejuni
isolates of foreign origin.
Conclusions: The results indicate that imported and domestic C. jejuni isolates differ significantly in several aspects
from each other.
Background
Campylobacter jejuni is a leading cause of bacterial enter-
itis in developed countries and the most commonly
reported zoonosis in the European Union [1]. C. jejuni
colonizes the gastrointestinal tract of many animals
including poultry and wild birds, cattle, pigs, cat and dog.
Eating undercooked poultry has been shown to be a risk
factor for campylobacteriosis also in Finland [2], how-
ever, poultry is colonized with Campylobacter to a signif-
icantly lower extent than in many other countries [3].
Epidemiological studies using serotyping and genotyping
methods have revealed a high diversity among C. jejuni
from different sources in Finland and the risk factors for
human Campylobacter infection may vary according to
the geographical area and even with age [4,5].
Although the genomes of several C. jejuni strains have
been sequenced [6-8], very little is still known about the
pathogenicity mechanisms and the virulence factors of
this common enteropathogen [9]. The acute Campylo-
bacter infection is often self-limited but in severe cases
antimicrobial and hospital treatment may be needed.
The reasons why certain patients develop a more serious
acute infection or late sequelae of the disease are not
understood.
Several studies have searched for the presence of puta-
tive virulence factors among Campylobacter isolates of
human and animal origin but only few studies have
been able to show an association between certain bac-
terial factors and the outcome of human Campylobacter
infection. Genes studied have usually included those
suggested to have a role in adhesion, colonization, inva-
sion and toxin production. The plasmid-associated gene
virB11 [ 1 0 ] ,a sw e l la st h eg e n e sciaB (Campylobacter
invasive antigen B) [11,12], and cj0486 encoding a puta-
tive sugar transporter [13] have been suggested to be
involved in invasiveness. In addition, pldA encoding
outer membrane phospholipase A [14], and ceuE encod-
ing enterochelin uptake binding protein [15] have been
studied. The genes cgtB [16] and wlaN [17] are involved
in the biosynthesis of lipooligosaccharide (LOS), which
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for the triggering of Guillain-Barré syndrome, an acute
peripheral polyneuropathy, after C. jejuni infection [18].
Cytolethal distending toxin (CDT, encoded by the gene
cluster cdtABC) has been present in most of the tested
isolates [19] but its role in the outcome of the disease
still remains uncertain. Likewise, a recent report showed
g-glutamyl transpeptidase (GGT, encoded by the gene
ggt) to have a role in the persistent colonization of the
avian gut [20], but its importance in the course of
human campylobacteriosis is not known.
We have recently demonstrated that C. jejuni isolates
of domestic origin and those highly susceptible for cipro-
floxacin were associated with a more severe form of
enteritis characterized by bloody stools [21]. Our aim in
the present study was to reveal other bacterial factors
that may affect the outcome of the C. jejuni infection in a
well-characterized clinical material including both infec-
tions acquired abroad or in Finland. For that purpose, we
analyzed 166 clinical isolates of C. jejuni for the produc-
tion of GGT and the presence of the genes virB11, ciaB,
cgtB, wlaN, cj0486, ceuE, pldA and cdtABC.
Methods
Patients and Campylobacter isolates
A total of 166 patients with sporadic stool culture-veri-
fied C. jejuni infection (no other bacterial enteropatho-
gens detected) were included in the present study. Their
stool samples were collected from July 1 to December 31,
2006, and they had returned questionnaires including
questions concerning travelling abroad within two weeks
b e f o r et h eo n s e to fs y m p t o m s ,t h ec l i n i c a lc o u r s eo ft h e
illness and antimicrobial therapy. The patients belonged
to a group of 192 persons (originally also including
C. coli positive patients), some results of which have ear-
lier been presented [21]. All the isolates were hippurate
positive and were stored at -70°C before analyzed.
Susceptibility testing
The minimal inhibitory concentration (MIC) values of
ciprofloxacin (Bayer, Leverkusen, Germany), doxycycline
(Orion Pharma, Espoo, Finland) and erythromycin
(Amdipharm Ltd, Dublin, Ireland) were determined by
an agar dilution method according to the CLSI guidelines
[22]. Mueller-Hinton agar (Oxoid, Basingstoke, UK)
plates supplemented with defibrinated sheep blood (5%)
and the control strain C. jejuni ATCC 33560 were used.
The susceptibility of the isolates was interpreted accord-
ing to CLSI [23]. The results of susceptibility of the iso-
lates to ciprofloxacin have been published earlier [21].
PFGE typing
PFGE analysis was performed for 75 (all 40 domestic
and all 35 travel-associated isolates collected in July, as
t h ep r e v a l e n c eo fc a s e sp e rm o n t hw a st h eh i g h e s t
during this month) isolates as described earlier [3,24].
Isolate was considered to represent a new type when
PFGE KpnI profile differed by at least one band.
g-Glutamyl transpeptidase activity
In the first phase we studied the presence or absence of ggt
gene as described in our previous study [25]. All isolates
positive for the gene were further analyzed for the produc-
tion of GGT. Qualitative detection of GGT activity was
achieved as described previously for Helicobacter pylori
[26]. Briefly, approximately 10
9 bacteria were suspended in
a reagent containing 50 mM Tris (pH 8.25), 1.5 mM L-g-
glutamyl-carboxyl-3 nitro-4 anilide and 50 mM
glycylglycine. The mixture was incubated for 1 h at
37°C. Cleavage of the substrate by g-glutamyl transpepti-
dase turned the mixture yellow in color.
PCR detection of other putative C. jejuni virulence factors
DNA was extracted from C. jejuni isolates using the fol-
lowing protocols. Bacteria (10
8 CFU) were harvested
from blood agar plates (Columbia agar II containing 8%
vol/vol whole horse blood), dissolved in 500 μlo fd d H 2O
and incubated in a boiling water bath for 10 min. Cell
debris was removed by centrifugation at 18 000 g for
2 min. For some isolates DNA was extracted using either
a method utilizing guanidium thiocyanate [27], DNeasy
Blood & Tissue kit (Qiagen) or Wizard Genomic DNA
Purification Kit (Promega, UK) according to the manu-
facturer’s instructions. Successful extraction of template
C. jejuni DNA from each isolate was confirmed by PCR
amplification of the house keeping gene glyA.T h ep r e -
sence of the gene glyA and the putative virulence factors
virB11, ciaB, cgtB, wlaN, pldA, ceuE, Cj0486 as well as
the cdtABC operon were determined by PCR using the
primers listed in Table 1. The reaction mixture was pre-
p a r e di n1 ×A m p l i T a qG o l d3 6 0b u f f e rw i t h1 . 2 5 Uo f
AmpliTaq Gold 360 polymerase (Applied Biosystems,
USA), 200 μM dNTP (Fermentas, Germany), 0.2 μMo f
each primer (Eurogentec, Ougrée, Belgium) and 5 μlo f
template DNA in a total volume of 25 μl.
The PCR reactions started with a denaturation step at
95°C for 10 min. The cycling conditions were 25 cycles
of 95°C for 30 s, annealing temperatures (Table 1) for
30 s and 72°C for 60 s (120 s for cdtABC). For virB11
and glyA a touch down protocol was run with 5 cycles
at 53°C, 5 cycles at 52°C and 15 cycles at 51°C. The
reactions ended with an additional extension step at
72°C for 7 min. DNA extracted from C. jejuni NCTC
11168 was used as a positive control for the genes
cdtABC, wlaN and Cj0486 and DNA from C. jejuni
81176 served as a positive control for all other virulence
genes. A PCR reaction without added template was used
as a negative control.
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Statistical analyses were performed with GraphPad
Prism version 4.03 (GraphPad Software, San Diego, CA,
USA) and PASW Statistics 18 (SPSS for Windows, Rel.
18.0.2. 2010. SPSS Inc, Chicago, IL, USA). The c
2 test
and Fisher’s exact test were used for comparison of
categorical variables. Multivariate analyses were per-
formed with stepwise binary logistic regression models.
All tests were two-sided, and a p-value < 0.05 was con-
sidered to be significant.
The study was approved by the Ethics Committee of
the Hospital District of Helsinki and Uusimaa.
Results
Of the 166 cases of C. jejuni infection in the study 126
were acquired abroad and 40 were acquired in Finland.
Resistance to erythromycin (4 isolates) and resistance to
doxycycline (59 isolates) were only detected in isolates of
foreign origin. All except one of the isolates of domestic
origin were susceptible for ciprofloxacin whereas 83/126
(66%) of isolates of foreign origin were resistant to cipro-
floxacin, as published earlier [21]. Prevalence of the puta-
tive virulence markers among the isolates according to
MICs to ciprofloxacin and doxycycline, respectively, is
presented in Table 2. GGT-production was associated
with susceptibility to ciprofloxacin and doxycycline in the
univariate analysis. On the other hand, both ciprofloxa-
cin- and doxycycline-resistant isolates were more likely
than the susceptible ones to harbor the genes cj0486 and
ceuE (Table 2).
Contingency tables were also used to assess whether
the presence of putative virulence factors correlated
with clinical data. In the univariate analysis (Table 3),
GGT production and the presence of the gene cgtB
were associated with bloody stools. In addition, isolates
lacking the ceuE gene were associated with hospitaliza-
tion, as 8/24 (33%) of the patients infected with ceuE-
negative isolates were hospitalized, compared to 21/139
(15%) of those with ceuE-positive isolates (p = 0.031).
GGT production was strongly associated with infections
acquired in Finland as compared to infections from
abroad. On the other hand, the genes cj0486 and ceuE
were markedly more common among isolates of foreign
origin. Of all the domestic isolates, 34/40 (85%) showed
at least one of the following characteristics; GGT-pro-
duction, lack of cj0486 or absence of ceuE whereas the
number of foreign isolates was 60 (48%), respectively
(p < 0.0001). A total of 69/126 (55%) of the imported
isolates, but only 7/40 (18%) of the domestic isolates
were positive for both cj0486 and ceuE (p < 0.0001).The
significant findings in the univariate model were con-
trolled with a multivariate analysis to assess whether
some of the variables were independently associated
with each other. GGT-production was independently
associated with domestic infections, and the genes
cj0486 and ceuE were independently associated with
imported infections, respectively (Table 4). Although
bloody diarrhea was significantly associated with both
GGT-production and the presence of cgtB in the uni-
variate analysis, this factor could not be further analyzed
with a multivariate analysis as the proportion of missing
data in the questionnaires regarding this specific finding
was too high (28%).
PFGE analysis with KpnI digested samples revealed
that among the 40 domestic isolates, a total of 32 PFGE
types were identified indicating a high diversity.
Table 1 Primer sequences, annealing temperatures and PCR product sizes for the putative virulence factors studied
Gene Primers Sequence (5’-3’) Annealing temp (°C) Product (bp) Reference
glyA Gly-Fw
Gly-rev
GAGTTAGAGCGTCAATGTGAAGG
AAACCTCTGGCAGTAAGGGC
53-51 1052 [36]
virB11 VirB-232
VirB-701
TCTTGTGAGTTGCCTTACCCCTTTT
CCTGCGTGTCCTGTGTTATTTACCC
53 494 [35]
ceuE CeuE405F
CeuE405R
GATAAAGTCGTTGGCGTTCC
GCGAGATTGGAGGACCAAAGG
60 405 *
ciaB ciaB355F
ciaB355R
CAGAAGGAGAAATTTGTGAGC
ATATCCCATTCTAATGCCACC
58 355 *
pldA pldA-84fwd
pld-981rev
AAGCTTATGCGTTTTT
TATAAGGCTTTCTCCA
45 913 [35]
Cj0486 Cj0486fwd
Cj0486rev
GATAGAGCATTAAATTGGGATG
CCTATAAAGCCATACCAAGCC
58 1263 [13]
wlaN wlaN-DL 39
Cj1139cF
TTAAGAGCAAGATATGAAGGTG
TGCTGGGTATACAAAGGTTGTG
60 434 [17,37]
cgtB wlaN-DL 39
cgtBrev
TTAAGAGCAAGATATGAAGGTG
GCACATAGAGAACGCTACAA
56 563 [17]
cdtABC LYA-F
MII-R
CTTTATGCATGTTCTTCTAAATTT
GTTAAAGGTGGGGTTATAATCATT
55 2111 [38]
*Personal communication: Rafal Gierczyński, National Institute of Public Health, Warsaw, Poland.
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lyzed had different PFGE profiles, which did not overlap
with those of domestic isolates. Thus, the isolates were
highly diverse and did not seem to have a common
source.
Discussion
We recently showed that bloody stools were more com-
mon among patients infected with C. jejuni isolates of
domestic origin and those highly susceptible for cipro-
floxacin [21]. C. jejuni isolates of Finnish origin have
even earlier been shown to differ significantly from those
of foreign origin as being almost exclusively susceptible
for ciprofloxacin [28,29]. In the present study, we further
analyzed possible differences between C. jejuni isolates
acquired in Finland and those from abroad and screened
for the presence of certain putative virulence markers.
Significant differences were detected as GGT production
was independently associated with infection of domestic
origin and the isolates of foreign origin significantly more
often harbored the genes cj0486 and ceuE,f i n d i n g sa l s o
verified with a multivariate analysis.
GGT is an enzyme present in both bacteria and eukar-
yotes. It has a role in glutathione and glutamine meta-
bolism in C. jejuni [30]. The presence of ggt has been
shown to vary among C. jejuni isolates [20,31] and we
Table 2 Contingency table results for antimicrobial susceptibility and putative virulence markers among 166 C. jejuni
isolates
MIC values Putative virulence factor
GGT-
production
virB11 ciaB cgtB wlaN cj0486 ceuE pldA cdtABC
Ciprofloxacin MIC ≤ 1
(82/166) *
20/82
(p = 0.001) §
1/82 81/82 16/82 17/82 31/82 62/82 52/82 69/82
Ciprofloxacin MIC ≥ 4
(84/166) †
5/84 3/84 83/84 15/84 22/84 50/84
(p = 0.0051) ¶
80/84
(p = 0.0003) ¶
49/84 62/84
Doxycycline MIC ≤ 2
(102/166) *
22/102
(p = 0.0032) §
1/102 101/102 22/102 20/102 40/102 82/102 59/102 82/102
Doxycycline MIC ≥ 4
(64/166) ‡
3/64 3/64 63/64 9/64 19/64 41/64
(p = 0.0018) #
60/64
(p < 0.0001) #
42/64 49/64
No. positive isolates
(%)
25/166
(15%)
4/166
(2.4%)
164/166
(99%)
31/166
(19%)
39/166
(23%)
81/166
(49%)
142/166
(86%)
101/166
(61%)
131/166
(79%)
*interpreted as susceptible, †interpreted as resistant, ‡interpreted as resistant or intermediate (5 isolates with MIC 4 mg/L), §associated with susceptible isolates,
¶associated with resistant isolates, #associated with resistant or intermediate isolates
Table 3 Characteristics of 166 patients and putative virulence factors present in the respective C. jejuni isolates
Clinical characteristics Putative virulence factor
GGT-
production
virB11 ciaB cgtB wlaN cj0486 CeuE pldA cdtABC
Female sex (99/166) 17/99 3/99 98/99 19/99 23/99 52/99 85/99 62/99 78/99
Underlying disease
(38/162)
9/38 3/38 37/38 10/38 9/38 18/38 32/38 23/38 31/38
Domestic infection
(40/166)
16/40
(p < 0.0001) *
1/40 40 9/40 8/40 7/40 26/40 25/40 34/40
Infection from abroad
126/166)
9/126 3/126 124/126 22/126 31/126 74/126
(p < 0.0001) †
116/126
(p < 0.0001) †
76/126 97/126
Vomiting (41/156) 8/41 1/41 40/41 8/41 9/41 17/41 34/41 25/41 32/41
Fever (136/156) 20/136 4/136 134/136 27/136 30/136 66/136 115/136 82/136 104/136
Bloody stools (21/119) 6/21
(p = 0.025)
1/21 21 8/21
(p = 0.034)
3/21 9/21 17/21 16/21 18/21
Long-lasting (≥ 10 d)
diarrhea (42/161)
6/42 1/42 42 12/42
(p = 0.051)
7/42 18/42 35/42 24/42 31/42
Hospitalization (29/163) 3/29 1/29 29 7/29 8/29 15/29 21/29
(p = 0.031) ‡
19/29 23/29
No. positive isolates (%) 25/166
(15%)
4/166
(2.4%)
164/166
(99%)
31/166
(19%)
39/166
(23%)
81/166
(49%)
142/166
(86%)
101/166
(61%)
131/166
(79%)
*associated with domestic infection, †associated with infection from abroad, ‡the absence of ceuE associated with hospitalization
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human and chicken C. jejuni isolates but significantly
less common among bovine isolates [25]. GGT activity
in C. jejuni has been suggested to affect the persistent
colonization of the avian gut [20] and in a mouse model
for C. jejuni it was shown to enhance colonization [30].
In our study, GGT-production was present in 15% of
the isolates and associated with bloody diarrhea in the
univariate analysis, although the latter, due to a lack of
data available, could not be further analyzed in a multi-
variate analysis. Interestingly, the domestic C. jejuni iso-
lates were able to produce GGT significantly more often
than the imported isolates, a finding also verified by the
multivariate analysis. PFGE typing of all domestic iso-
lates verified the sporadic nature of the domestically
acquired infections confirming also that GGT produc-
tion was not linked with a certain genotype.
The gene cj0486, encoding a putative sugar transpor-
ter and suggested to be related to invasiveness [13], as
well as the gene ceuE, encoding a transport protein for
uptake of the siderophore enterochelin [32] were
detected in 49% and 86% of the isolates in the present
study, respectively, in line with some other reports [19].
Although their presence was not associated with the
o u t c o m eo ft h ed i s e a s e ,i n t e r e s t i n g l yt h e yw e r es i g n i f i -
cantly more often found among isolates of foreign than
among those of domestic origin. Furthermore, the iso-
lates lacking ceuE seemed to cause infections requiring
hospital treatment, but this finding was not verified by
the multivariate analysis. In addition to the typing of all
domestic isolates, PFGE typing of travel-associated iso-
lates from July indicated that almost all patients had
unique genotypes and none of the studied characteristics
was linked with a genotype. Travel-associated isolates
originated from a total of 36 different countries.
Only few studies have been promising in trying to
show correlation between putative virulence factors or
the characteristics of C. jejuni and the outcome of the
disease. Of the different C. jejuni markers studied in the
present report, GGT production and the presence of
cgtB were associated with bloody stools in the univariate
analysis, but the other putative virulence factors did not
correlate with any specific clinical findings. The ß-1,3
galactosyltransferase gene cgtB in the LOS gene clusters
A and B involved in the biosynthesis of ganglioside-like
LOS [16,17] also showed a trend of being associated
with longer-lasting diarrhea. C. jejuni LOS gene clusters
A, B and C have even earlier been associated not only
with a more severe outcome of the disease as character-
ized by bloody stools and longer duration of diarrhea
but also with the development of post-infectious compli-
cations [33]. However, in the present study, the other
ß-1,3 galactosyltransferase gene wlaN, expressed in the
LOS gene cluster C [34] was not associated with any
clinical characteristics. The gene ciaB has been sug-
gested to be involved in invasiveness [11,12] and thus,
could be needed for the development of the disease.
Indeed, all except two of the 166 isolates in our study
were ciaB positive, which is in line with earlier reports
[19,35]. The presence of another putative virulence fac-
tor the gene pldA, encoding phospholipase A [14], was
detected in the present study to a somewhat lower
extent (61%) as compared to other reports (91-100%)
[19,35], and did not correlate with the clinical outcome
of the disease. As CDT and virB11 were concerned, our
results supported those of others showing CDT activity
in the great majority [19] but the presence of virB11 in
only a tiny proportion [13,19] of clinical C. jejuni iso-
lates. Thus, it seems very unlikely that these particular
markers would play a role in the diversity of the out-
come of the human disease.
Conclusions
In conclusion, we suggest for the first time that GGT
production could be a marker associated with a more
severe outcome of C. jejuni infection as characterized by
bloody stools, however, additional work is needed
to clarify the importance of this finding. Furthermore, to
the best of our knowledge, this is the first report to
describe the presence of putative virulence markers sig-
nificantly and independently to differ between C. jejuni
isolates of foreign and domestic origin. Whether this
also reflects the different sources of C. jejuni infections
locally in Finland remains to be studied.
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